Quick Answer
IRADIMED CORP reported Stockholders Equity of $94.62 million for fiscal year 2025.
IRADIMED CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $94.62M | +9.0% |
| 2024 | $86.82M | +21.6% |
| 2023 | $71.42M | -3.1% |
| 2022 | $73.67M | +2.1% |
| 2021 | $72.17M | +17.6% |
| 2020 | $61.38M | +10.6% |
| 2019 | $55.52M | +32.4% |
| 2018 | $41.95M | +27.4% |
| 2017 | $32.93M | +3.3% |
| 2016 | $31.89M | -0.1% |
| 2015 | $31.93M | +52.9% |
| 2014 | $20.89M | +285.2% |
| 2013 | $5.42M | +68.4% |
| 2012 | $3.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $98.35M | +17.9% | +4.3% |
| June 30, 2025 | $94.30M | +18.4% | +4.7% |
| March 31, 2025 | $90.05M | +18.3% | +3.7% |
| December 31, 2024 | $86.82M | +21.6% | +4.1% |
| September 30, 2024 | $83.43M | +11.9% | +4.7% |
| June 30, 2024 | $79.67M | +15.5% | +4.7% |
| March 31, 2024 | $76.12M | +18.3% | +6.6% |
| December 31, 2023 | $71.42M | -3.1% | -4.2% |
- IRADIMED CORP showed an increase of +9.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, IRADIMED CORP’s stockholders equity has grown by 2838.3% (from $3.22 million to $94.62 million).
- The most recent figure is from IRADIMED CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: